Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Lindsay Joyce Brubaker

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-OB/GYN GONC GENERAL OPS
ORCID ORCID Icon0000-0001-8986-2915 Additional info

    Collapse Overview 

    Collapse Research 
    Collapse research activities and funding
    889342     (Lindsay W Brubaker)Feb 1, 2022 - Jan 31, 2025
    Ovarian Cancer Research Alliance
    Targeting Chromobox 2 to overcome macrophage-induced immune suppression
    Role: PI

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Brubaker LW, Backos DS, Nguyen VT, Reigan P, Yamamoto TM, Woodruff ER, Iwanaga R, Wempe MF, Kumar V, Persenaire C, Watson ZL, Bitler BG. Novel chromobox 2 inhibitory peptide decreases tumor progression. Expert Opin Ther Targets. 2023 Apr-May; 27(4-5):361-371. PMID: 37243607.
      View in: PubMed
    2. Smith LP, Brubaker LW, Wolsky RJ. It Does Exist! Diagnosis and Management of Thyroid Carcinomas Originating in Struma Ovarii. Surg Pathol Clin. 2023 Mar; 16(1):75-86. PMID: 36739168.
      View in: PubMed
    3. Sanders BE, Wolsky R, Doughty ES, Wells KL, Ghosh D, Ku L, Pressey JG, Bitler BB, Brubaker LW. Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations. Gynecol Oncol Rep. 2022 Dec; 44:101077. PMID: 36249907.
      View in: PubMed
    4. Haag JG, Adler AD, Sheeder J, Brubaker LW, Lefkowits C. Patterns of palliative care referral in platinum resistant ovarian cancer demonstrate reactive rather than proactive approach. Gynecol Oncol Rep. 2022 Oct; 43:101053. PMID: 35958954.
      View in: PubMed
    5. Steinhart B, Jordan KR, Bapat J, Post MD, Brubaker LW, Bitler BG, Wrobel J. The Spatial Context of Tumor-Infiltrating Immune Cells Associates with Improved Ovarian Cancer Survival. Mol Cancer Res. 2021 12; 19(12):1973-1979. PMID: 34615692.
      View in: PubMed
    6. Johnson S, Renz M, Wheeler L, Diver E, Dorigo O, Litkouhi B, Behbakht K, Howitt B, Karam A. Vulvar sarcoma outcomes by histologic subtype: a Surveillance, Epidemiology, and End Results (SEER) database review. Int J Gynecol Cancer. 2020 08; 30(8):1118-1123. PMID: 32641392.
      View in: PubMed
    7. Wheeler LJ, Guntupalli SR. Female Sexual Dysfunction: Pharmacologic and Therapeutic Interventions. Obstet Gynecol. 2020 07; 136(1):174-186. PMID: 32541291.
      View in: PubMed
    8. Guntupalli SR, Brennecke A, Behbakht K, Tayebnejad A, Breed CA, Babayan LM, Cheng G, Ramzan AA, Wheeler LJ, Corr BR, Lefkowits C, Sheeder J, Matsuo K, Flink D. Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial. JAMA Netw Open. 2020 06 01; 3(6):e207410. PMID: 32589230.
      View in: PubMed
    9. Watson ZL, Yamamoto TM, McMellen A, Kim H, Hughes CJ, Wheeler LJ, Post MD, Behbakht K, Bitler BG. Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma. Clin Epigenetics. 2019 11 27; 11(1):165. PMID: 31775874.
      View in: PubMed
    10. Wheeler LJ, Desanto K, Teal SB, Sheeder J, Guntupalli SR. Intrauterine Device Use and Ovarian Cancer Risk: A Systematic Review and Meta-analysis. Obstet Gynecol. 2019 10; 134(4):791-800. PMID: 31503144.
      View in: PubMed
    11. Ross ME, Wheeler LJ, Flink DM, Lefkowits C. Pre-operative opioid use in gynecologic oncology: a common comorbidity relevant to the peri-operative period. Int J Gynecol Cancer. 2019 11; 29(9):1411-1416. PMID: 31473659.
      View in: PubMed
    12. Wheeler LJ, Watson ZL, Qamar L, Yamamoto TM, Sawyer BT, Sullivan KD, Khanal S, Joshi M, Ferchaud-Roucher V, Smith H, Vanderlinden LA, Brubaker SW, Caino CM, Kim H, Espinosa JM, Richer JK, Bitler BG. Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer Dissemination. iScience. 2019 Sep 27; 19:474-491. PMID: 31437751.
      View in: PubMed
    13. Moroney MR, Wheeler LJ, Corr BR. Clinical presentation of brain metastases from endometrial carcinoma: A case series. Gynecol Oncol Rep. 2019 May; 28:79-83. PMID: 30963086.
      View in: PubMed
    14. Wheeler LJ, Watson ZL, Qamar L, Yamamoto TM, Post MD, Berning AA, Spillman MA, Behbakht K, Bitler BG. CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer. Oncogenesis. 2018 Nov 26; 7(11):92. PMID: 30478317.
      View in: PubMed
    15. Bitler BG, Watson ZL, Wheeler LJ, Behbakht K. PARP inhibitors: Clinical utility and possibilities of overcoming resistance. Gynecol Oncol. 2017 12; 147(3):695-704. PMID: 29037806.
      View in: PubMed
    16. Wheeler L, Westhoff GL, O'Keefe MC, Kong CS, Karam A. Adenocarcinoma With Breast/Adnexal and Upper Gastrointestinal Differentiation Arising in an Ovarian Mature Cystic Teratoma: A Case Report and Review of the Literature. Int J Gynecol Pathol. 2016 Jan; 35(1):72-7. PMID: 26352552.
      View in: PubMed
    Brubaker's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (86) concept(s)
    _
    Co-Authors Expand Description
    See all (28) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)